Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner

• Main Authors: Hausenloy D.J., Whittington H.J., Wynne A.M., Begum S.S., Theodorou L., Riksen N., Mocanu M.M., Yellon D.M.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: BioMed Central 2018
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/143923
• Institution: National University of Singapore

10.1186/1475-2840-12-154